Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter McLaughlin

Showing results (41-50 of 116) with videos related to

Pageof 12
Sort By:
Leukemia & Lymphoma|October 27, 2006
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphomaBarbara Pro, Fredrick B Hagemeister, Peter McLaughlin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 7, 2002
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbitBita Esmaeli, James L Murray, M Amir Ahmadi, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Plos One|August 13, 2013
Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphomaZheng Chen, Eric F Pittman, Jorge Romaguera, et al.
Leukemia & Lymphoma|January 7, 2006
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphomaBarbara Pro, Luis Fayad, Peter McLaughlin, et al.
Leukemia & Lymphoma|October 29, 2002
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphomaApostolia-Maria Tsimberidou, Yunfang Jiang, Richard J Ford, et al.
Cancer|December 19, 2007
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphomaYasuhiro Oki, Barbara Pro, Luis E Fayad, et al.
Cancer|November 1, 2008
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphomaMichael Wang, Luis Fayad, Fernando Cabanillas, et al.
Leukemia & Lymphoma|May 24, 2011
Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference reportThomas E Witzig, Paul Fishkin, Leo I Gordon, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective studyChul S Ha, Joseph S Kong, Susan L Tucker, et al.
Pageof 12

Showing results (41-50 of 116) with videos related to

Sort By:
Pageof 12
Leukemia & Lymphoma|October 27, 2006
Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphomaBarbara Pro, Fredrick B Hagemeister, Peter McLaughlin, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 7, 2002
Immunotherapy for low-grade non-hodgkin secondary lymphoma of the orbitBita Esmaeli, James L Murray, M Amir Ahmadi, et al.
Cancer Journal (Sudbury, Mass.)|March 6, 2004
Molecular response of follicular lymphoma to cyclophosphamide, doxorubicin, vincristine, prednisone C(H)OP or COP-based therapy as measured by polymerase chain reaction evidence of translocation (14;18)(q32;q21)Chul S Ha, Ming-Sheng Lee, Peter McLaughlin, et al.
Plos One|August 13, 2013
Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphomaZheng Chen, Eric F Pittman, Jorge Romaguera, et al.
Leukemia & Lymphoma|January 7, 2006
Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphomaBarbara Pro, Luis Fayad, Peter McLaughlin, et al.
Leukemia & Lymphoma|October 29, 2002
Quantitative real-time polymerase chain reaction for detection of circulating cells with t(14;18) in volunteer blood donors and patients with follicular lymphomaApostolia-Maria Tsimberidou, Yunfang Jiang, Richard J Ford, et al.
Cancer|December 19, 2007
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphomaYasuhiro Oki, Barbara Pro, Luis E Fayad, et al.
Cancer|November 1, 2008
Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphomaMichael Wang, Luis Fayad, Fernando Cabanillas, et al.
Leukemia & Lymphoma|May 24, 2011
Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference reportThomas E Witzig, Paul Fishkin, Leo I Gordon, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Central lymphatic irradiation for stage I-III follicular lymphoma: report from a single-institutional prospective studyChul S Ha, Joseph S Kong, Susan L Tucker, et al.
Pageof 12